Study Shows Influenza Vaccines Cause Spontaneous Abortions and Stillbirths

Study Shows Influenza Vaccines Cause Spontaneous Abortions and Stillbirths



A comparison of fetal-loss reports in the Vaccine
Adverse Event Reporting System (VAERS) during three consecutive
influenza seasons shows there was a synergistic toxicity causing
spontaneous abortions (SAB) and stiillbirths (SB) following the Center
for Disease Control (CDC) recommendations of pandemic and influenza
vaccines administered to pregnant women.




An overwhelming majority of pregnant women who visit the doctor's office are now refusing the flu vaccine over fears it will harm their fetus
and their fears are now scientifically justified. More than 90% of all
expecting mothers will now say no to the flu vaccine due to fear of
miscarriage and delivery of toxic byproducts to their unborn child.

In 2011, Dr. Alessandro Bertoucci who analyzed
the practices of 256 physicians treating more than 600,000 patients,
reported that a staggering 91% of pregnant women are declining
influenza vaccines due to fears of miscarriage and suspected toxins in
the vaccine itself.

A study published last
year in the Human and Experimental Toxicology journal found a direct
statistical correlation between higher vaccine doses and infant
mortality rates. It was a confirmation that many anti-vaccine advocates
have long awaited and further establishes and adds to preliminary
evidence that vaccinations are toxic poisons having no place in the
human body.

The study, Infant
mortality rates regressed against number of vaccine doses
routinely given: Is there a biochemical or synergistic toxicity?, was conducted by Gary S. Goldman and Neil Z. Miller who has been studying the dangers of vaccines for 25 years.

The infant mortality rate (IMR) is one of the most
important indicators of the socio-economic well-being and public
health conditions of a country. The US childhood immunization schedule
specifies 26 vaccine doses for infants aged less than 1 year--the
most in the world--yet 33 nations have lower IMRs. Australia and
Canada are a close 2nd and 3rd respectively with 24 vaccine doses.

Some countries have IMRs that are less than half
the US rate: Singapore, Sweden, and Japan are examples. According to the
Centers for Disease Control and Prevention (CDC), "The relative
position of the United States in comparison to countries with the
lowest infant mortality rates appears to be worsening."

Goldman's most recent study Comparison of VAERS fetal-loss reports during three consecutive influenza seasons
successfully correlated fetal toxicity resulting from the
administration of both the pandemic (A-H1N1) and seasonal influenza
vaccines during the 2009/10 season.

Since 1997, the Advisory Committee on
Immunization Practices (ACIP) has recommended the routine vaccination
of pregnant women with trivalent inactivated influenza vaccine (TIV)
after the first trimester of pregnancy. This recommendation was expanded
in 2004 to include all trimesters of pregnancy.


All previously published studies of pregnant
women who were administered TIV have reported this vaccine as safe
during all stages of pregnancy.

Frequently cited peer-reviewed reports
on the safety of influenza vaccination during pregnancy do not reveal
any adverse outcomes among women. Many of these studies, used “no
Thimerosal” influenza vaccines, had insufficient statistical power to
adequately detect and assess complications due to the small sample
size.

In another follow-up safety study (conducted
among 2,291 pregnant women) cited by ACIP did not find increased childhood mortality associated with exposure to TIV in pregnancy. However, fetallosses were not included in the analysis as found in critical assessments of the study.

The safety and effectiveness of the pandemic
(monovalent influenza) A-H1N1 vaccine had not been previously
established in pregnant women. Nor was the combination of two different
influenza vaccines ever tested in pregnant women. The A-H1N1 vaccine
inserts from the various manufacturers contained this caution: “It is
also not known whether these vaccines can cause fetal harm when
administered to pregnant women or can affect reproduction capacity.”

In October 2010, Moro et al summarized that
during 19 influenza seasons (1990/91 through 2008/09) there were a
total of 17 spontaneous abortion (SAB) and 6 stillbirth (SB) reports
following TIV in VAERS database.


An independent survey was conducted by the National Coalition of Organized Women
(NCOW) via the Internet to serve as a second surveillance source for
pregnant women suffering A-H1N1 fetal loss during the two-vaccine
2009/10 influenza season. Eileen Dannemann, director of NCOW, oversaw
this study and the data collected are summarized in the Results
section. In response to a public service announcement delivered via
several websites on the Internet, respondents contacted one of two
study coordinators via phone or e-mail address. The respondents
provided relevant details including (a) type of influenza vaccine
received, (b) date of vaccination, (c) type of vaccine, (d) date of
onset of symptom(s), (e) date of spontaneous abortion or miscarriage,
(f) geographic location, (g) whether or not the adverse event was
reported to VAERS, and (h) other miscellaneous comments.

Results from Goldman's study shows that although
there was an approximate 4-fold (43%/11.3%) increase in the percentage
of pregnant women vaccinated in 2009/10 compared to 2008/09, there was a
43.5-fold increase in fetal-loss reports--from 4 in 2008/09 to 174 in
2009/10.

Based on respondents’ comments to the NCOW survey in the 2009/10
season, it is likely that the ascertainment-corrected rate of 535 fetal
losses per million pregnant women vaccinated represents a significant
underestimate during the two-vaccine 2009/10 influenza season since
healthcare professionals explained to patients “the benefits of
influenza vaccination outweighed the risks.” Medical literature
reporting the mean rate of “1.9 fetal losses per million pregnant women
vaccinated” for the previous 19 single-vaccine influenza seasons based
on counts of VAERS reports that were not adjusted for
under-ascertainment, likely contributed to this perception of safety.
Because both patient and healthcare professionals relied on a
historical profile that was incomplete with respect to assessing
fetal-demise reporting, a possible link to fetal demise following
administration of influenza vaccine(s) during 2009/10 was rarely
contemplated or was considered highly unlikely and thus, more often
than not, not reported.

When one or more Thimerosal-containing vaccines,
including some formulations of the seasonal TIV and pandemic monovalent
A-H1N1 vaccines are administered to a pregnant woman, the fetus is also
indirectly exposed to mercury.

The linkage between Thimerosal and neurodevelopmental disorders is a concern because several studies
have shown that children with autistic spectrum disorders (ASDs) have
higher levels of mercury body burden than typically developing
children. In addition, there is a positive correlation between mercury
body burden and severity of ASD symptoms. Direct measurement of injury
in the brains of children with ASD reinforce this finding; there is a
significant dose-dependent positive correlation between oxidative
stress markers (evidence of brain injury) and mercury levels in the
brains of children with ASD.

The amount of mercury that accumulates in any given fetus and the
severity of its impact depend upon several factors in addition to the
maternal mercury exposure due to injected Thimerosal-containing
inactivated-influenza vaccines. Dental amalgams in pregnant woman
contribute to increased mercury burden in the developing fetus and
newborn. Also, the maternal-fetal genetic background can modulate
fetal exposure to mercury; thus, certain gene variants influence
mercury toxicokinetics causing the variable susceptibility that is
observed with respect to mercury toxicity. This variation in genetic
susceptibility, combined with factors of diet and antibiotic use, can
synergistically enhance mercury toxicity and effectively preclude
establishment of a safe mercury dosing level for all individuals.

Moreover, the 0.1 mcg/kg-day reference dose that the Environmental
Protection Agency (EPA) established as safe based on oral ingestion of
mercury is not applicable for injected Thimerosal via vaccination since
injection bypasses the absorption protection provided by the
gastrointestinal system intestines (which is also apparently dependent
on the manner in which the fish or other mercury-containing food is
prepared), thereby delivering more of the toxic dose of mercury
administered into the body.

Thus, it is biologically plausible that during the two-vaccine
2009/10 influenza season, when pregnant women were administered two
Thimerosal-containing influenza vaccines each delivering 50 mcg of
Thimerosal (or 25 mcg of mercury per dose), the fetus’ mercury dose
exceeded the EPAs reference (oral) dose for oral exposure of (0.1 mcg
of mercury/kg-day). This over-exposure could be a significant
contributing factor to some of the reported SABs and SBs. Moreover,
the mercury in injected Thimerosal-containing vaccine doses has been
found to preferentially bioaccumulate in the fetal tissues.

The study concluded that the concomitant administration of the
seasonal influenza and pandemic A-H1N1 vaccines during 2009/10,
suggests a synergistic toxicity and a statistically significant higher
rate of fetal loss reporting relative to the single-dose seasons.

The VAERS rates of 6.8 and 12.6 fetal-loss reports per million women
vaccinated for those single-vaccine seasons may provide healthcare
professionals with a sense that influenza vaccines administered during
pregnancy are relatively safe, when, in reality, these rates merely
reflect the low level of case ascertainment associated with VAERS and
thus, grossly underestimate the true rates encountered in the U.S.
population. Just because a single vaccine has been tested and
considered safe, does not imply there will not be a synergistic fetal
toxicity effect associated with the administration of two or more
Thimerosal-containing vaccines to a pregnant woman and/or a synergistic
toxicity effect from the combination of the biologically active
components contained in concomitantly administered vaccines.

In addition, because of the order of magnitude increase in
fetal-loss report rates, from 6.8 fetal-loss reports per million
pregnant woman vaccinated in the 1-dose 2008/09 season to 77.8 in the
2-dose 2009/10 season, further long-term studies are needed to assess
adverse outcomes in the surviving children. Additional research
concerning the risk factors associated with the potential synergistic
toxicity associated with the administration of Thimerosal-containing
vaccines is warranted and the exposure-effect association should be
verified in further toxicological and case-control studies.

Source:-
http://preventdisease.com/news/12/090412_Study-Shows-Influenza-Vaccines-Caused-Spontaneous-Abortions-and-Stillbirths.shtml